Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | 15-12G | Securities registration termination [Section 12(g)] |
|
1 | |
| 12/16/25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] |
|
  |
157 |
| 12/12/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/12/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/12/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/12/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/12/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/12/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
